General Information of the Compound
Compound ID
CP0941680
Compound Name
1-(2-(piperidin-1-yl)ethyl)-4-(pyridin-2-yl)-1H-pyrazolo[3,4-d]pyrimidine
    Show/Hide
Structure
Formula
C17H20N6
Molecular Weight
308.389
Canonical SMILES
c1ccc(-c2ncnc3c2cnn3CCN2CCCCC2)nc1
    Show/Hide
InChI
InChI=1S/C17H20N6/c1-4-8-22(9-5-1)10-11-23-17-14(12-21-23)16(19-13-20-17)15-6-2-3-7-18-15/h2-3,6-7,12-13H,1,4-5,8-11H2
    Show/Hide
InChIKey
DVHZJSVERMNRTN-UHFFFAOYSA-N
Physicochemical Property
logP
2.3742
Rotatable Bonds
4
Heavy Atom Count
23
Polar Areas
59.73
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 90146246
ChEMBL ID
CHEMBL4292265
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 634 nM
   TI
   LI
   LO
   TS